1,644 results on '"Langley, R."'
Search Results
152. Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study
153. Rotation of the Earth from Lunar Laser Ranging
154. Studies of Tantalum Nitride Thin Film Resistors
155. Depth Profiling of Deuterium and Helium in Metals by Elastic Proton Scattering: A Measurement of the Enhancement of the Elastic Scattering Cross Section Over Rutherford Scattering Cross Section
156. Our Unused Influence
157. Implantation and Diffusion of Au in Be: Behavior During Annealing of a Low-Solubility Implant
158. Safety of Certolizumab Pegol in Chronic Plaque Psoriasis: Cumulative Data Over 48 Weeks' Exposure from Phase 3, Multicenter, Randomized, Placebo-Controlled Studies
159. Enhanced Polar Outflow Probe Ionospheric Radio Occultation Measurements at High Latitudes: Receiver Bias Estimation and Comparison With Ground-Based Observations
160. Sécukinumab et grossesse : résultats des données globales de tolérance
161. ATM loss, MSI and survival in the MAGIC trial
162. Concurrent, Multi-Band, Single-Chain Radio Receiver for High Data-Rate HetNets
163. Concurrent, Tunable, Multi-Band, Single Chain Radio Receivers for 5G RANs
164. Tunable, concurrent multiband, single chain radio architecture for low energy 5G-RANs
165. 2004.
166. Study of the diffusion of Au and Ag in Be using ion beams.
167. No Epstein-Barr Virus Infection and Extremely Rare Mismatch Repair Deficiency in Oesophageal Cancer
168. LBA-03Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: results from the UK Medical Research Council randomised OEO5 trial (ISRCTN 01852072)
169. Electron number density profiles derived from radio occultation on the CASSIOPE spacecraft
170. 855PD - Docetaxel for hormone-naïve prostate cancer (PCa): Results from long-term follow-up of non-metastatic (M0) patients in the STAMPEDE randomised trial
171. Correction of the anion gap for albumin in order to detect occult tissue anions in shock
172. Effect of low-dose aspirin use on survival of patients with gastrointestinal malignancies; an observational study
173. Infections à Candida et infections récidivantes : analyse de 10 études cliniques de phases 2 et 3 de sécukinumab dans le psoriasis modéré à sévère
174. Rapidité d’action de l’ixékizumab : analyse groupée de 2 essais randomisés de phase 3 (UNCOVER-2 et 3) chez des patients atteints de psoriasis
175. Tuneable dual-band antenna for sub 1 GHz cellular mobile radio applications
176. A randomised phase II study of perioperative epirubicin, cisplatin and capecitabine (ECX) ± lapatinib for operable, HER-2 positive gastric, oesophagogastric junctional (OGJ) or lower oesophageal adenocarcinoma: Results from the UK MRC ST03 lapatinib feasibility study (ISRCTN 46020948)
177. 053 Evaluation of inflammatory bowel disease in patients with plaque psoriasis studied in phase 3 trials of ixekizumab (UNCOVER Trials): Adjudicated data from the induction period
178. Demonstration of RF Digitising Concurrent Dual-Band Receiver for Carrier Aggregation over TV White Spaces
179. 056 Impact of ixekizumab on palmoplantar plaque psoriasis compared to placebo and etanercept: results from UNCOVER 2
180. 054 Treatment with ixekizumab over 60 weeks provides sustained improvements in health-related quality of life: Results from UNCOVER-1, a randomized phase 3 trial
181. 388 Ixekizumab, a novel anti-IL-17A antibody, exhibits low immunogenicity during long-term treatment in patients with psoriasis
182. Investigation of the role of gastroenteritis causing viruses in the asymptomatic neonatal digestive tract
183. A sparse FSS for control of radio coverage in buildings
184. Analysis of electric field strength for planning indoor 5.8 GHz wireless networks
185. Gain enhancement of implanted antenna using lens and parasitic ring
186. ROLE OF TUMOR NECROSIS FACTOR AND INTERFERON GAMMA IN ENDOTOXIN-INDUCED E-SELECTIN EXPRESSION
187. Tohoku-Oki earthquake caused major ionospheric disturbances at 450 km altitude over Alaska
188. Auswirkung von Secukinumab auf Psoriasis Symptomatik und physikalische Funktionen verglichen mit Placebo und Etanercept bei Probanden mit moderater bis schwerer Plaque-Psoriasis und Psoriasis Arthritis
189. 637P - Magnetic resonance imaging in oesophageal (oes) cancer: Results from the STO3 MRI substudy
190. Gold films for the control and utilisation of radiant energy
191. Scanning ultrastructure of the stria vascularis
192. A model for edge scattering from dichroic surfaces
193. Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate‐to‐severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE‐2 and AMAGINE‐3.
194. Efficacy and safety of continuous every‐2‐week dosing of ixekizumab over 52 weeks in patients with moderate‐to‐severe plaque psoriasis in a randomized phase III trial (IXORA‐P).
195. Matching‐adjusted indirect comparison of efficacy in patients with moderate‐to‐severe plaque psoriasis treated with ixekizumab vs. secukinumab.
196. An Integrated Clinico-Metabolomic Model Improves Prediction of Death in Sepsis
197. Zum Nachweis, zur Bestimmung und Trennung des Zinks
198. Über die Bestimmung des Niobs und Tantals
199. Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus
200. Management of R&D program evaluations: A case study of Canada's energy R&D program
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.